TI: Ozone Therapy in Rheumatic Diseases DT: September 1985 AU: Dr. Med. Ziad Fahmy, Chief Physician, Augusta Klinik, 6550 Bad Kreuznach, F.R.G. SO: Presented at the 7th Ozone World Congress - Tokyo 9th - 12th September, 1985 AB: Among the disorders collectively termed as rheumatism, progressive chronic polyarthritis constitutes a great problem, not only as regards the frequency of its occurrence - 1 - 3 % of the population - but also as regards its most effective therapy. Apart from non-medicational (or physical) therapy methods, long-term antirheumatics, or so- called basic therapeutics, represent the only medicaments known to have effects on the pathological processes involved going beyond a symptomatic influence - contrary to the non- steroid artirheumatics and the corticoids. In medical ozone research over the recent years, we have arrived at results which confirm the necessity for therapeutical application of an ozone-oxygen gas mixture, not only clinically, but also biochemically.